טוען...
Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)(2) in macaque()
To warrant potential clinical testing, the equine anti-SARS–CoV F(ab′)(2) requires evaluation in as many animal models as possible and a safety test in a primate model. In this study, we evaluated the pharmacokinetics, tolerance and immunity of this kind of antibody in macaques and rats. Results sho...
שמור ב:
| הוצא לאור ב: | Int Immunopharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7106090/ https://ncbi.nlm.nih.gov/pubmed/17996696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2007.09.011 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|